Biological and clinical role of angiogenesis in breast cancer Giampietro Gasparini OriginalPaper Pages: 103 - 107
The influence of angiogenesis research on management of patients with breast cancer Judah Folkman OriginalPaper Pages: 109 - 118
The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression Olga V. VolpertVeronica StellmachNoel Bouck OriginalPaper Pages: 119 - 126
The role of vascular endothelial growth factor in pathological angiogenesis Napoleone Ferrara OriginalPaper Pages: 127 - 137
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis Walter KolchGeorg Martiny-BaronDieter Marmé OriginalPaper Pages: 139 - 155
Molecular and pharmacologic targeting of angiogenesis factors — the example of pleiotrophin Frank CzubaykoAnke M. SchulteAnton Wellstein OriginalPaper Pages: 157 - 168
Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors Noel Weidner OriginalPaper Pages: 169 - 180
Novel methods for the determination of the angiogenic activity of human tumors Mattia BarbareschiGiampietro GaspariniPaolo Dalla Palma OriginalPaper Pages: 181 - 192
Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression Masakazu ToiKazuo InadaTakeshi Tominaga OriginalPaper Pages: 193 - 204
Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma — results of a multiparametric study Pierantonio BevilacquaMattia BarbareschiGiampietro Gasparini OriginalPaper Pages: 205 - 217
The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium S B FoxG D H TurnerAL Harris OriginalPaper Pages: 219 - 226
Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma Beverly A. TeicherSylvia A. HoldenDonna Goff OriginalPaper Pages: 227 - 236
Antibody-directed targeting of the vasculature of solid tumors Philip E. ThorpeFrancis J. Burrows OriginalPaper Pages: 237 - 251
The clinical experience with antiangiogenic agents John L. MarshallMichael J. Hawkins OriginalPaper Pages: 253 - 261
